Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Conditions

Lymphedema 2Neoplasms 1Menorrhagia 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × pycnogenols × Clear all
NCT03704454 2018-10-12

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Legacy Health System

Phase NA Unknown
40 enrolled

Menorrhagia

NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed
2 enrolled

Lymphedema

NCT00064857 2008-04-22

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
26 enrolled

Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡